Logo
ASEAN Pharmaceutical Manufacturing Market 2017-2027

ASEAN Pharmaceutical Manufacturing Market 2017-2027

Bonafide Trust 30-03-2021 66 Pages Figures : 29 Tables : 25
Region : Asia-Pacific Category : Lifescience Healthcare

ASEAN pharmaceutical manufacturing industry will grow by 12.8% annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic. Highlighted with 25 tables and 39 figures, this 66-page report “ASEAN Pharmaceutical Manufacturing Market 2017-2027 by Formulation and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire ASEAN pharmaceutical manufacturing industry and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Industry Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Industry Opportunities • Porter’s Fiver Forces The trend and outlook of ASEAN industry is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify ASEAN pharmaceutical manufacturing industry in every aspect of the classification from perspectives of Formulation and Country. Based on Formulation, the ASEAN industry is segmented into the following sub-markets with annual production value for 2017-2027 included in each section. • Tablets • Capsules • Injectable • Sprays • Suspensions • Powders • Other Formulations Geographically, the following national/local markets are fully investigated: • Indonesia • Thailand • Philippines • Vietnam • Singapore • Malaysia • Myanmar • Cambodia • Laos • Brunei For each key country, detailed analysis and data for annual production value are available for 2017-2027. The breakdown of key national industry by Formulation and Manufacturer is also included. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services